Le Lézard
Classified in: Ebola virus, Science and technology, Business
Subject: INO

Communication Equipment Stocks' Research Reports Released on Infinera, Knowles, Lumentum, and Ericsson

NEW YORK, Feb. 5, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the investment community.  Today we are offering reports on INFN, KN, LITE, and ERIC which can be accessed for free by signing up to www.wallstequities.com/registration. On Friday, the NASDAQ Composite ended the day at 7,240.95, down 1.96%; the Dow Jones Industrial Average edged 2.54% lower, to finish at 25,520.96; and the S&P 500 closed at 2,762.13, marginally slipping 2.12%. Losses were broad based as all sectors finished the trading session in red. WallStEquities.com has initiated research reports on the following Communication Equipment stocks: Infinera Corp. (NASDAQ: INFN), Knowles Corp. (NYSE: KN), Lumentum Holdings Inc. (NASDAQ: LITE), and Telefonaktiebolaget LM Ericsson (publ) (NASDAQ: ERIC). All you have to do is sign up today for this free limited time offer by clicking the link below. www.wallstequities.com/registration


Sunnyvale, California headquartered Infinera Corp.'s stock finished Friday's session 0.77% lower at $6.47 with a total trading volume of 956,802 shares. The Company's shares are trading below their 50-day moving average by 5.64%. Moreover, shares of Infinera, which provides optical transport networking equipment, software, and services worldwide, have a Relative Strength Index (RSI) of 40.66. Get the full research report on INFN for free by clicking below at: www.wallstequities.com/registration/?symbol=INFN


Shares in Itasca, Illinois headquartered Knowles Corp. declined 2.64%, ending last Friday's session at $14.77 with a total trading volume of 867,555 shares, which was higher than their three months average volume of 777.59 thousand shares. The Company's shares are trading below their 50-day moving average by 4.38%. Moreover, shares of Knowles, which designs, manufactures, and sells micro-acoustic, audio processing, and specialty component solutions to the mobile consumer electronics, communications, medical, military, aerospace, and industrial markets worldwide, have an RSI of 37.16. Gain free access to the research report on KN at: www.wallstequities.com/registration/?symbol=KN

Lumentum Holdings

On Friday, Milpitas, California headquartered Lumentum Holdings Inc.'s stock saw a decline of 6.37%, to close the day at $44.85. A total volume of 3.17 million shares was traded, which was higher than their three months average volume of 2.30 million shares. The Company's shares have advanced 18.49% over the last twelve months. The stock is trading below its 50-day moving average by 11.95%. Additionally, shares of Lumentum, which manufactures and sells optical and photonic products for optical networking and commercial laser customers worldwide, have an RSI of 41.21.

On January 24th, 2018, research firm Stifel reiterated its 'Buy' rating on the Company's stock with a decrease of the target price from $75 a share to $66 a share. Register for your free report coverage on LITE at: www.wallstequities.com/registration/?symbol=LITE

Telefonaktiebolaget LM Ericsson

Shares in Stockholm, Sweden headquartered Telefonaktiebolaget LM Ericsson ended the day 1.05% higher at $6.71. A total volume of 7.15 million shares was traded, which was above their three months average volume of 4.82 million shares. The stock has gained 14.31% over the last twelve months. The Company's shares are trading above their 50-day and 200-day moving averages by 0.77% and 3.96%, respectively. Furthermore, shares of Ericsson, which provides telecommunications equipment and related services to mobile and fixed network operators, have an RSI of 46.83.

On February 01st, 2018, research firm Canaccord Genuity reiterated its 'Hold' rating on the Company's stock with a decrease of the target price from $6.50 a share to $6 a share. Get the free research report on ERIC at: www.wallstequities.com/registration/?symbol=ERIC


Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

WSE has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/


For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@wallstequities.com
Phone number: +21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE Wall St. Equities

These press releases may also interest you

at 10:07
In response to the Ebola outbreak that claimed more than 10,000 lives in West Africa four years ago, Canada and China worked on a new Ebola vaccine. Created by the Chinese Academy of Military Medical Sciences' Bioengineering Institute and CanSino...

19 mar 2018
NanoViricides, Inc. (the "Company") has announced that it has expanded its in vivo testing agreement with the University of Wisconsin to encompass testing its topical anti-herpes agents in animal models of HSV-induced dermal, ocular and genital...

15 mar 2018
"Little x Little," a global movement led by Generation Z to fix the future, officially launched today, setting an audacious goal of inspiring 2 billion acts of good by 2030 in support of the United Nations' Sustainable Development Goals. To...

14 mar 2018
The global Wound Healing market was valued at approximately US$ 23.3 Bn in 2016 is projected to register cumulative annual growth rate (CAGR) of over 4.8% from 2017 to 2025, according to a new report published by Transparency Market Research titled...

12 mar 2018
The "Global Viral Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering. Global Viral Partnering 2012 to 2018 provides the full collection of Viral disease deals signed between the...

8 mar 2018
Notice is given to the Shareholders of Essity Aktiebolag (publ) ("Essity") of the Annual General Meeting of Shareholders to be held on Thursday 12 April 2018, at 3 p.m.at Stockholm Waterfront Congress Centre, Nils Ericsons Plan 4, Stockholm...

News published on 5 february 2018 at 07:10 and distributed by: